Michael Cangelosi
- Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthmaBy Robert Niven, Michael Simmonds, Michael Cangelosi, Narinder Shargill, Dominic Tilden and Suzanne CottrellRobert Niven1North West Lung Research Center, University of Manchester & University Hospital of South Manchester, Manchester, United KingdomMichael Simmonds2Health Economics & Government Affairs, Boston Scientific Corporation, Sydney, AustraliaMichael Cangelosi3Health Economics and Reimbursement, Boston Scientific Corporation, Marlborough, MA United StatesNarinder Shargill4Clinical Affairs, Boston Scientific Corporation, San Jose, CA United StatesDominic Tilden5Health Economics, THEMA Consulting, Sydney, AustraliaSuzanne Cottrell5Health Economics, THEMA Consulting, Sydney, Australia
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.